Claire E. O'Hanlon

Claire E. O'Hanlon
Associate Policy Researcher; Professor of Policy Analysis, Pardee RAND Graduate School


Ph.D. in policy analysis, Pardee RAND Graduate School; M.P.P., University of Chicago; B.S. in engineering, Harvey Mudd College


Claire E. O’Hanlon is an associate policy researcher at RAND. O’Hanlon is a health services and policy researcher experienced in applied qualitative, quantitative, and mixed methods. Her research interests include quality measurement and quality improvement for patients with serious and chronic conditions. Recently her work has focused on patient experience measures in diagnosis, clinical outcome assessments for use in clinical trials, and brief evidence reviews for health and mental health topics. Other interests include health care delivery systems and consolidation, palliative and end-of-life care, and emerging health technologies. Her work has been cited in the New York Times, Washington Post, The Hill, congressional testimony, and various trade publications and military news sources. 

O'Hanlon was previously a Health Science Specialist at the Veterans Affairs Greater Los Angeles Healthcare System, where she completed a postdoctoral fellowship in health services research. O’Hanlon has previously worked in health economics and outcomes modeling at Amgen, University of Chicago Medicine, and Knopp Biosciences, as well as in the hard sciences as a laboratory technician at Duquesne University, where she designed drug delivery agents. O’Hanlon holds a doctorate in policy analysis from Pardee RAND Graduate School, Master of Public Policy from the University of Chicago Harris School, certificate in health administration and policy from the University of Chicago, and B.S. in engineering from Harvey Mudd College. In 2018 she was named a Delivery Systems Science Fellow by AcademyHealth and a “40-for-40” outstanding early career research professional by the Association for Public Policy Analysis and Management.

Selected Publications

O’Hanlon CE, Giannitrapani KF, Lindvall C, Gamboa RC, Garrido M, Asch S, Canning M, the ImPACS Patient and Family Caregiver Panel, Walling AM, Lorenz KA, "Patient and caregiver prioritization of palliative and end-of-life cancer care quality measures," Journal of General Internal Medicine, 2021

O'Hanlon, Claire E., Carrie M. Farmer, Jamie L. Ryan, and Natalie C. Ernecoff, Clinical Outcome Assessments and Digital Health Technologies Supporting Clinical Trial Endpoints in Early Parkinson's Disease: Roundtable Proceedings and Roadmap for Research, RAND Corporation (CF-A2550-1), 2023

O’Hanlon CE, "Impacts of health care consolidation in Pittsburgh, Pennsylvania: a qualitative study," Inquiry, 2020

O’Hanlon CE, Kranz AM, DeYoreo M, Mahmud A, Damberg CL, Timbie JW, "Access, quality, and financial performance of rural hospitals following health system affiliation," Health Affairs, 2019

O’Hanlon CE, Whaley C, Freund D, "Medical practice consolidation and physician shared patient network size, strength, and stability," Medical Care, 2019

O'Hanlon CE, "What can state regulators and lawmakers do when federal antitrust enforcement fails to prevent health care consolidation?" Health Affairs Blog, 2019

O’Hanlon C, Huang C, Sloss E, Anhang Price R, Hussey P, Farmer C, Gidengil C, "Comparing VA and non-VA quality of care: a systematic review," Journal of General Internal Medicine, 2016


  • Neurological Disorders

    New Clinical Outcome Assessments Could Improve Treatment for Parkinson's

    The prevalence of Parkinson's disease has doubled over the last 25 years, and over 8.5 million people are living with the disease worldwide, but treatment options are limited. The development of new clinical outcome assessments could lead to new treatments for the disease.

    Apr 25, 2023

    The RAND Blog

  • Primary Care

    Doing More with Less: Lessons from Cuba's Health Care System

    High U.S. health care costs do not yield corresponding health outcomes for its citizens. But Cuba, for less than a tenth of U.S. costs, has attained comparable outcomes on many indicators, such as life expectancy and infant mortality. Cuba prioritizes primary care and prevention and addresses social determinants of health.

    Oct 6, 2017

    Georgetown Journal of International Affairs